56
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Once-daily indacaterol 75 μg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients’ perceived onset of effect

, , , &
Pages 919-925 | Published online: 01 Sep 2014

Figures & data

Table 1 Patient’s global satisfaction with the onset of effect and patient’s expectation of treatment adherence

Table 2 Demographics of the patient population (full analysis set) (means [standard deviations] are reported, unless otherwise stated)

Table 3 Primary and exploratory variables during treatment with indacaterol and placebo in the full analysis set (treatment sequences combined)

Table 4 Cumulative frequencies for time until patient’s perception of onset of effect by sequence and treatment (full analysis set)

Figure 1 Cumulative distribution functions for time to patient’s perception of onset of effect by treatment.

Figure 1 Cumulative distribution functions for time to patient’s perception of onset of effect by treatment.